Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human Genetics of Addiction: New Insights and Future Directions
Dana B. Hancock, Christina A. Markunas, Laura J. Bierut, et al.
Current Psychiatry Reports (2018) Vol. 20, Iss. 2
Open Access | Times Cited: 139

Showing 1-25 of 139 citing articles:

The Neuroscience of Drug Reward and Addiction
Nora D. Volkow, Michael Michaelides, Rubén Baler
Physiological Reviews (2019) Vol. 99, Iss. 4, pp. 2115-2140
Open Access | Times Cited: 582
Genetic impacts on DNA methylation: research findings and future perspectives
Sergio Villicaña, Jordana T. Bell
Genome biology (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 166
Dorsal Striatal Circuits for Habits, Compulsions and Addictions
David M. Lipton, Ben J. Gonzales, Ami Citri
Frontiers in Systems Neuroscience (2019) Vol. 13
Open Access | Times Cited: 148
Multi-ancestry meta-analysis of tobacco use disorder identifies 461 potential risk genes and reveals associations with multiple health outcomes
Sylvanus Toikumo, Mariela Jennings, Benjamin K. Pham, et al.
Nature Human Behaviour (2024) Vol. 8, Iss. 6, pp. 1177-1193
Open Access | Times Cited: 17
Expanding the genetic architecture of nicotine dependence and its shared genetics with multiple traits
Bryan C. Quach, Michael J. Bray, Nathan Gaddis, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 110
Genome-wide association study of smoking trajectory and meta-analysis of smoking status in 842,000 individuals
Ke Xu, Boyang Li, Kathleen A. McGinnis, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 104
Recent Efforts to Dissect the Genetic Basis of Alcohol Use and Abuse
Sandra Sanchez‐Roige, Abraham A. Palmer, Toni‐Kim Clarke
Biological Psychiatry (2019) Vol. 87, Iss. 7, pp. 609-618
Open Access | Times Cited: 92
Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond
Nathan Gaddis, Ravi Mathur, Jesse A. Marks, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 52
Genetics of substance use disorders: a review
Joseph D. Deak, Emma C. Johnson
Psychological Medicine (2021) Vol. 51, Iss. 13, pp. 2189-2200
Open Access | Times Cited: 49
Genetics of alcohol use disorder: a review
Joseph D. Deak, Alex P. Miller, Ian R. Gizer
Current Opinion in Psychology (2018) Vol. 27, pp. 56-61
Open Access | Times Cited: 54
Heterogeneity and Polygenicity in Psychiatric Disorders: A Genome-Wide Perspective
Frank R. Wendt, Gita A. Pathak, Daniel S. Tylee, et al.
Chronic Stress (2020) Vol. 4
Open Access | Times Cited: 49
Effect of short-term prescription opioids on DNA methylation of the OPRM1 promoter
José Vladimir Sandoval-Sierra, Francisco I. Salgado García, Jeffrey H. Brooks, et al.
Clinical Epigenetics (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 40
Ferroptosis-Related Genes in Neurodevelopment and Central Nervous System
Soo-Whee Kim, Yu-Jin Kim, Sung Eun Kim, et al.
Biology (2021) Vol. 10, Iss. 1, pp. 35-35
Open Access | Times Cited: 35
Reducing maladaptive behavior in neuropsychiatric disorders using network modification
Nicholas M. Timme
Frontiers in Psychiatry (2025) Vol. 15
Open Access
Genetics of Substance Use Disorders
David Goldman, Danielle Sambo
Oxford University Press eBooks (2025), pp. 621-634
Closed Access
<p><em>OPRM1</em> A118G Polymorphisms and Its Role in Opioid Addiction: Implication on Severity and Treatment Approaches</p>
Malik Mumtaz Taqi, Muhammad Faisal, Hadar Zaman
Pharmacogenomics and Personalized Medicine (2019) Vol. Volume 12, pp. 361-368
Open Access | Times Cited: 39
Identifying Early Risk Factors for Addiction Later in Life: a Review of Prospective Longitudinal Studies
Angelica M. Morales, Scott A. Jones, Dakota Kliamovich, et al.
Current Addiction Reports (2019) Vol. 7, Iss. 1, pp. 89-98
Open Access | Times Cited: 35
The Gut Microbiome and Substance Use Disorder
Jordan T. Russell, Yanjiao Zhou, George M. Weinstock, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 29
Smoking among inpatients in treatment for substance use disorders: prevalence and effect on mental health and quality of life
Lars Lien, Ingeborg Bolstad, Jørgen G. Bramness
BMC Psychiatry (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 26
Understanding the genetics and neurobiological pathways behind addiction (Review)
Alexandra Popescu, Maria Marian, Ana Miruna Drăgoi, et al.
Experimental and Therapeutic Medicine (2021) Vol. 21, Iss. 5
Open Access | Times Cited: 24
Why do we climb mountains? An exploration of features of behavioural addiction in mountaineering and the association with stress-related psychiatric disorders
Leonie Habelt, Georg Kemmler, Michaela Defrancesco, et al.
European Archives of Psychiatry and Clinical Neuroscience (2022) Vol. 273, Iss. 3, pp. 639-647
Open Access | Times Cited: 16
Genetic control of DNA methylation is largely shared across European and East Asian populations
Alesha Hatton, Feifei Cheng, Tian Lin, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Enhanced Novel Object Recognition and Spatial Memory in Rats Selectively Bred for High Nicotine Preference
Eren Bekci, Ramazan Can Gokmen, Lütfiye Kanıt, et al.
Brain Sciences (2024) Vol. 14, Iss. 5, pp. 427-427
Open Access | Times Cited: 3
Genome-wide DNA methylation differences in nucleus accumbens of smokers vs. nonsmokers
Christina A. Markunas, Stephen A. Semick, Bryan C. Quach, et al.
Neuropsychopharmacology (2020) Vol. 46, Iss. 3, pp. 554-560
Open Access | Times Cited: 27
Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms?
Marjorie C. Gondré‐Lewis, Igor Elman, Tanya N. Alim, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 870-870
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top